المؤلفون: Nasrazadani A; Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. anasrazadani1@mdanderson.org., Li Y; Department of Biostatistics, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, USA.; Eli Lilly and Company, Indianapolis, IN, USA., Fang Y; Department of Biostatistics, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, USA., Shah O; Graduate Program in Integrated Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA., Atkinson JM; Women's Cancer Research Center, UPMC Hillman Cancer Center, Magee-Womens Research Institute, Pittsburgh, PA, USA., Lee JS; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., McAuliffe PF; Women's Cancer Research Center, UPMC Hillman Cancer Center, Magee-Womens Research Institute, Pittsburgh, PA, USA.; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Bhargava R; Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA., Tseng G; Department of Biostatistics, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, USA., Lee AV; Women's Cancer Research Center, UPMC Hillman Cancer Center, Magee-Womens Research Institute, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Magee Women's Hospital, Suite 4628, 300 Halket Street, Pittsburgh, PA, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA., Lucas PC; Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Magee Women's Hospital, Suite 4628, 300 Halket Street, Pittsburgh, PA, USA.; NSABP Foundation, Inc, Pittsburgh, PA, USA., Oesterreich S; Women's Cancer Research Center, UPMC Hillman Cancer Center, Magee-Womens Research Institute, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Magee Women's Hospital, Suite 4628, 300 Halket Street, Pittsburgh, PA, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA., Wolmark N; UPMC Hillman Cancer Center, Magee Women's Hospital, Suite 4628, 300 Halket Street, Pittsburgh, PA, USA.; NSABP Foundation, Inc, Pittsburgh, PA, USA.

المصدر: British journal of cancer [Br J Cancer] 2023 Apr; Vol. 128 (6), pp. 1030-1039. Date of Electronic Publication: 2023 Jan 05.

نوع المنشور: Meta-Analysis; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Lobular*/drug therapy , Carcinoma, Ductal, Breast*/pathology , Breast Neoplasms*/pathology , Carcinoma, Intraductal, Noninfiltrating*, Humans ; Female ; Retrospective Studies

المؤلفون: Canas-Marques R; Department of Pathology, Champalimaud Foundation, Lisboa, Portugal., Schnitt SJ; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Breast Oncology Program, Dana-Farber Cancer Institute, Boston, MA, USA. sschnitt@bwh.harvard.edu.

المصدر: British journal of cancer [Br J Cancer] 2023 Mar; Vol. 128 (5), pp. 713-714. Date of Electronic Publication: 2023 Jan 27.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Intraductal, Noninfiltrating*/pathology , Carcinoma in Situ*/pathology , Carcinoma, Ductal, Breast*/pathology , Breast Neoplasms*, Humans ; Female ; Neoplasm Invasiveness

المؤلفون: Morrissey RL; Genetics and Epigenetics Program at The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thompson AM; Division of Surgical Oncology, Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Lozano G; Genetics and Epigenetics Program at The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. gglozano@mdanderson.org.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. gglozano@mdanderson.org.

المصدر: British journal of cancer [Br J Cancer] 2022 Nov; Vol. 127 (10), pp. 1744-1754. Date of Electronic Publication: 2022 Jun 28.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Intraductal, Noninfiltrating*/genetics , Carcinoma, Intraductal, Noninfiltrating*/pathology , Carcinoma, Ductal, Breast*/pathology , Carcinoma in Situ*, Animals ; Mice ; Humans ; Tumor Suppressor Protein p53/genetics ; Mutation ; Disease Progression

المؤلفون: Almekinders MM; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Bismeijer T; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kumar T; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.; Department of Genetics, MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Houston, TX, USA., Yang F; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA., Thijssen B; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Linden R; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van Rooijen C; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Vonk S; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Sun B; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA., Parra Cuentas ER; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA., Wistuba II; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA., Krishnamurthy S; Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA., Visser LL; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Seignette IM; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hofland I; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Sanders J; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Broeks A; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Love JK; Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Menegaz B; Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Wessels L; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Thompson AM; Division of Surgical Oncology, Baylor College of Medicine, Houston, TX, USA., de Visser KE; Oncode Institute, Utrecht, The Netherlands.; Division of Tumour Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Hooijberg E; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Lips E; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Futreal A; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA., Wesseling J; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. j.wesseling@nki.nl.; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. j.wesseling@nki.nl.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. j.wesseling@nki.nl.

مؤلفون مشاركون: Grand Challenge PRECISION Consortium

المصدر: British journal of cancer [Br J Cancer] 2022 Oct; Vol. 127 (7), pp. 1201-1213. Date of Electronic Publication: 2022 Jun 29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology , Carcinoma, Ductal, Breast*/pathology , Carcinoma, Intraductal, Noninfiltrating*/pathology, Biomarkers, Tumor/analysis ; CD8-Positive T-Lymphocytes/pathology ; Female ; Forkhead Transcription Factors ; Humans ; Ki-67 Antigen ; Tumor Microenvironment

المؤلفون: Allen V; Program for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, ON, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, K1H 8M5, ON, Canada., Coulombe J; Program for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, ON, Canada., Zhao H; Program for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, ON, Canada., Kreps LM; Program for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, ON, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, K1H 8M5, ON, Canada., Cook DP; Program for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, K1H 8M5, ON, Canada., Pryce B; Program for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, K1H 8M5, ON, Canada., Clemons M; Program for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, ON, Canada.; Department of Medicine, University of Ottawa, Ottawa, K1H 8M5, ON, Canada., Vanderhyden BC; Program for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, K1H 8M5, ON, Canada., Gray DA; Program for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, ON, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, K1H 8M5, ON, Canada., Addison CL; Program for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, ON, Canada. caddison@ohri.ca.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, K1H 8M5, ON, Canada. caddison@ohri.ca.; Department of Medicine, University of Ottawa, Ottawa, K1H 8M5, ON, Canada. caddison@ohri.ca.

المصدر: British journal of cancer [Br J Cancer] 2022 Jul; Vol. 127 (1), pp. 56-68. Date of Electronic Publication: 2022 Mar 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology , Carcinoma, Ductal, Breast*/pathology , Carcinoma, Lobular*/metabolism, Animals ; Cell Line, Tumor ; Female ; Heterografts ; Humans ; Receptors, Estrogen/metabolism

المؤلفون: Giannakeas V; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.; ICES, Toronto, ON, Canada., Lim DW; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada., Narod SA; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. steven.narod@wchospital.ca.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. steven.narod@wchospital.ca.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. steven.narod@wchospital.ca.

المصدر: British journal of cancer [Br J Cancer] 2021 Aug; Vol. 125 (4), pp. 601-610. Date of Electronic Publication: 2021 May 26.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*epidemiology , Carcinoma, Ductal, Breast/*epidemiology , Neoplasms, Second Primary/*epidemiology, Adult ; Age Factors ; Aged ; Aged, 80 and over ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Carcinoma, Ductal, Breast/metabolism ; Carcinoma, Ductal, Breast/pathology ; Female ; Humans ; Middle Aged ; Neoplasm Staging ; Neoplasms, Second Primary/metabolism ; Neoplasms, Second Primary/pathology ; Receptors, Estrogen/metabolism ; Risk Factors ; SEER Program

المؤلفون: Vaidya JS; Division of Surgery and Interventional Science, University College London, London, UK. jayantvaidya@gmail.com., Bulsara M; Department of Biostatistics, University of Notre Dame, Fremantle, WA, Australia., Baum M; Division of Surgery and Interventional Science, University College London, London, UK., Wenz F; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Massarut S; Department of Surgery, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Pigorsch S; Department of Radiation Oncology, Red Cross Hospital, Technical University of Munich, Munich, Germany., Alvarado M; Department of Surgery, University of California, San Francisco, CA, USA., Douek M; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Saunders C; School of Surgery, University of Western Australia, Perth, WA, Australia., Flyger H; Department of Breast Surgery, University of Copenhagen, Copenhagen, Denmark., Eiermann W; Department of Gynecology and Obstetrics, Red Cross Hospital, Technical University of Munich, Munich, Germany., Brew-Graves C; Division of Surgery and Interventional Science, University College London, London, UK., Williams NR; Division of Surgery and Interventional Science, University College London, London, UK., Potyka I; Division of Surgery and Interventional Science, University College London, London, UK., Roberts N; Division of Surgery and Interventional Science, University College London, London, UK., Bernstein M; Patient advocate and writer, London, UK., Brown D; Department of Surgery, Ninewells Hospital, Dundee, UK., Sperk E; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Laws S; Department of Surgery, Royal Hampshire County Hospital, Winchester, UK., Sütterlin M; Department of Gynecology and Obstetrics, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Berlin, Germany., Corica T; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia., Lundgren S; Department of Oncology, St Olav's University Hospital, & Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Holmes D; John Wayne Cancer Institute & Helen Rey Breast Cancer Foundation, University of Southern California, Los Angeles, CA, USA., Vinante L; Department of Radiation Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Bozza F; Department of Surgery, Instituto Oncologico Veneto (IVO) IRCCS, Padoa, Italy., Pazos M; Department of Radiation Oncology, University Hospital, Ludwig Maximilians Universitat, Munich, Germany., Blanc-Onfroy ML; Oncologie radiothérapeute, Institut de Cancérologie de l'Ouest, Nantes, France., Gruber G; Brust Zentrum Seefeld, Zurich, Switzerland., Polkowski W; Department of Surgical Oncology, Medical University of Lublin, Lublin, Poland., Dedes KJ; Breast Center, Universitätsspital Zürich, Zurich, Switzerland., Niewald M; Saarland University Medical Center, Homburg, Germany., Blohmer J; Sankt Gertrauden-Krankenhaus, and The Charité-Universitätsmedizin Berlin, Berlin, Germany., McReady D; Princess Margaret Cancer Centre, Toronto, Canada., Hoefer R; Sentara Surgery Specialists, Hampton, VA, USA., Kelemen P; Ashikari Breast Center, New York Medical College, New York, NY, USA., Petralia G; Department of Surgery, University College London Hospitals, London, UK., Falzon M; Department of Pathology University College London Hospitals, London, UK., Joseph D; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia., Tobias JS; Department of Clinical Oncology, University College London Hospitals, London, UK.

المصدر: British journal of cancer [Br J Cancer] 2021 Aug; Vol. 125 (3), pp. 380-389. Date of Electronic Publication: 2021 May 25.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*radiotherapy , Breast Neoplasms/*surgery , Carcinoma, Ductal, Breast/*radiotherapy , Carcinoma, Ductal, Breast/*surgery , Mastectomy, Segmental/*methods, Aged ; Aged, 80 and over ; Breast Neoplasms/pathology ; Carcinoma, Ductal, Breast/pathology ; Combined Modality Therapy ; Female ; Humans ; Intraoperative Care ; Middle Aged ; Prognosis ; Survival Analysis ; Treatment Outcome ; Tumor Burden ; Whole-Body Irradiation

المؤلفون: Badve SS; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA. sbadve@iupui.edu., Cho S; GE Research, Niskayuna, NY, 12309, USA., Gökmen-Polar Y; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA., Sui Y; GE Research, Niskayuna, NY, 12309, USA., Chadwick C; GE Research, Niskayuna, NY, 12309, USA., McDonough E; GE Research, Niskayuna, NY, 12309, USA., Sood A; GE Research, Niskayuna, NY, 12309, USA., Taylor M; Department of Oncology, Cancer and Haematology Centre, Oxford University, Oxford, OX37LJ, UK., Zavodszky M; GE Research, Niskayuna, NY, 12309, USA., Tan PH; Department of Pathology, Singapore General Hospital, Singapore, Singapore., Gerdes M; GE Research, Niskayuna, NY, 12309, USA., Harris AL; Department of Oncology, Cancer and Haematology Centre, Oxford University, Oxford, OX37LJ, UK., Ginty F; GE Research, Niskayuna, NY, 12309, USA.

المصدر: British journal of cancer [Br J Cancer] 2021 Mar; Vol. 124 (6), pp. 1150-1159. Date of Electronic Publication: 2021 Jan 07.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Biomarkers, Tumor/*metabolism , Breast Neoplasms/*pathology , Carcinoma, Ductal, Breast/*pathology , Carcinoma, Intraductal, Noninfiltrating/*pathology , Mastectomy/*methods, Aged ; Breast Neoplasms/metabolism ; Breast Neoplasms/therapy ; Carcinoma, Ductal, Breast/metabolism ; Carcinoma, Ductal, Breast/therapy ; Carcinoma, Intraductal, Noninfiltrating/metabolism ; Carcinoma, Intraductal, Noninfiltrating/therapy ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Prognosis ; Retrospective Studies ; Survival Rate

المؤلفون: Shaaban AM; Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK. a.shaaban@bham.ac.uk., Hilton B; Screening Quality Assurance Service, Public Health England, Birmingham, UK., Clements K; Screening Quality Assurance Service, Public Health England, Birmingham, UK., Provenzano E; Addenbrookes Hospital, Cambridge, UK.; Cambridge Breast Unit, and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Trust, Cambridge, UK., Cheung S; Screening Quality Assurance Service, Public Health England, Birmingham, UK., Wallis MG; Addenbrookes Hospital, Cambridge, UK.; Cambridge Breast Unit, and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Trust, Cambridge, UK., Sawyer E; School of Cancer & Pharmaceutical Sciences, King's College London and Guy's and St Thomas' Hospitals NHS Foundation Trust, London, UK., Thomas JS; Western General Hospital, Edinburgh, UK., Hanby AM; Leeds Institute of Medical Research at St. James's, St James's University Hospital, Leeds, UK., Pinder SE; School of Cancer & Pharmaceutical Sciences, King's College London and Guy's and St Thomas' Hospitals NHS Foundation Trust, London, UK., Thompson AM; Baylor College of Medicine, Houston, TX, USA.

مؤلفون مشاركون: Sloane Project Steering Committee

المصدر: British journal of cancer [Br J Cancer] 2021 Mar; Vol. 124 (5), pp. 1009-1017. Date of Electronic Publication: 2020 Nov 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*pathology , Carcinoma, Ductal, Breast/*pathology , Carcinoma, Intraductal, Noninfiltrating/*pathology, Breast Neoplasms/epidemiology ; Breast Neoplasms/surgery ; Carcinoma, Ductal, Breast/epidemiology ; Carcinoma, Ductal, Breast/surgery ; Carcinoma, Intraductal, Noninfiltrating/epidemiology ; Carcinoma, Intraductal, Noninfiltrating/surgery ; Female ; Follow-Up Studies ; Humans ; Mastectomy ; Prognosis ; Prospective Studies ; United Kingdom/epidemiology

المؤلفون: Zeng Y; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Gao W; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Chen X; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. chenxiaosong0156@hotmail.com., Shen K; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. kwshen@medmail.com.cn.

المصدر: British journal of cancer [Br J Cancer] 2021 Mar; Vol. 124 (5), pp. 975-981. Date of Electronic Publication: 2020 Dec 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*genetics , Breast Neoplasms/*pathology , Carcinoma, Ductal, Breast/*pathology , Carcinoma, Intraductal, Noninfiltrating/*pathology, Breast Neoplasms/genetics ; Carcinoma, Ductal, Breast/genetics ; Carcinoma, Intraductal, Noninfiltrating/genetics ; Female ; Follow-Up Studies ; Gene Expression Profiling ; Humans ; Middle Aged ; Prognosis ; Retrospective Studies ; Survival Rate